Efficacy of daratumumab in refractory primary Sjögren disease

Detalles Bibliográficos
Autores principales: Nocturne, Gaetane, Marmontel, Oriane, di Filippo, Mathilde, Chretien, Pascale, Krzysiek, Roman, Lifermann, Francois, Rahal, Nawal, Belkhir, Rakiba, Moulin, Philippe, Mariette, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Sjögren Syndrome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510860/
https://www.ncbi.nlm.nih.gov/pubmed/37730313
http://dx.doi.org/10.1136/rmdopen-2023-003464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510860/
https://www.ncbi.nlm.nih.gov/pubmed/37730313
http://dx.doi.org/10.1136/rmdopen-2023-003464

Ejemplares similares